Parotitis medical therapy: Difference between revisions
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The treatment of [[viral]] parotitis is largely supportive. [[Bacterial]] parotitis is targeted toward [[gram positive]] and [[anaerobic]] organisms. 70% of those cultured are [[beta-lactamase]] producers so [[augmentin]] is recommended. Antistaphylococcal penicillins are also advocated. Some suggest the addition of [[metronidazole]] or [[clindamycin]]. Systemic symptoms or failure to improve in 48 hrs warrants IV therapy and consideration of additional coverage for GNR. | The treatment of [[viral]] parotitis is largely supportive. [[Bacterial]] parotitis is targeted toward [[gram positive]] and [[anaerobic]] organisms. 70% of those cultured are [[beta-lactamase]] producers so [[augmentin]] is recommended. Antistaphylococcal penicillins are also advocated. Some suggest the addition of [[metronidazole]] or [[clindamycin]]. Systemic symptoms or failure to improve in 48 hrs warrants IV therapy and consideration of additional coverage for GNR. Adjunctive therapy with warm compresses, mouth irrigation, administration of [[sialogogue|sialagogue]]s (lemon drops), and bimanual massage of the gland intraorrally and externally can be employed. | ||
== References == | == References == |
Revision as of 21:59, 18 December 2012
Parotitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Parotitis medical therapy On the Web |
American Roentgen Ray Society Images of Parotitis medical therapy |
Risk calculators and risk factors for Parotitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
The treatment of viral parotitis is largely supportive. Bacterial parotitis is targeted toward gram positive and anaerobic organisms. 70% of those cultured are beta-lactamase producers so augmentin is recommended. Antistaphylococcal penicillins are also advocated. Some suggest the addition of metronidazole or clindamycin. Systemic symptoms or failure to improve in 48 hrs warrants IV therapy and consideration of additional coverage for GNR. Adjunctive therapy with warm compresses, mouth irrigation, administration of sialagogues (lemon drops), and bimanual massage of the gland intraorrally and externally can be employed.